31. Ibrutinib for the treatment of mantle cell lymphoma. Issue 5 (October 2014) Authors: Shah, Nimish; Hutchinson, Claire; Rule, Simon Journal: Expert review of hematology Issue: Volume 7:Issue 5(2014) Page Start: 521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study. Issue 10020 (20th February 2016) Authors: Dreyling, Martin; Jurczak, Wojciech; Jerkeman, Mats; Silva, Rodrigo Santucci; Rusconi, Chiara; Trneny, Marek; Offner, Fritz; Caballero, Dolores; Joao, Cristina; Witzens-Harig, Mathias; Hess, Georg; Bence-Bruckler, Isabelle; Cho, Seok-Goo; Bothos, John; Goldberg, Jenna D; Enny, Christopher; Traina... Journal: Lancet Issue: Volume 387:Issue 10020(2016) Page Start: 770 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. Ibrutinib‐associated lymphocytosis corresponds to bone marrow involvement in mantle cell lymphoma. (6th January 2015) Authors: Furtado, Michelle; Wang, Michael L.; Munneke, Brian; McGreivy, Jesse; Beaupre, Darrin M.; Rule, Simon Journal: British journal of haematology Issue: Volume 170:Number 1(2015:Jul.) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS study. Issue 9 (2nd September 2018) Authors: Cramer, Paula; Fraser, Graeme; Santucci-Silva, Rodrigo; Grosicki, Sebastian; Dilhuydy, Marie-Sarah; Janssens, Ann; Loscertales, Javier; Rule, Simon; Goy, Andre; Traina, Shana; Chan, Eric K. H.; Diels, Joris; Sengupta, Nishan; Mahler, Michelle; Salman, Mariya; Howes, Angela; Chanan-Khan, Asher Journal: Leukemia & lymphoma Issue: Volume 59:Issue 9(2018) Page Start: 2075 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis. (2nd December 2018) Authors: Brown, Jennifer R.; Moslehi, Javid; Ewer, Michael S.; O'Brien, Susan M.; Ghia, Paolo; Cymbalista, Florence; Shanafelt, Tait D.; Fraser, Graeme; Rule, Simon; Coutre, Steven E.; Dilhuydy, Marie‐Sarah; Cramer, Paula; Jaeger, Ulrich; Dreyling, Martin; Byrd, John C.; Treon, Steven; Liu, Emily Y.; Chan... Journal: British journal of haematology Issue: Volume 184:Number 4(2019) Page Start: 558 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. Is Good Clinical Practice Becoming Poor Clinical Care?. Issue 1 (December 2017) Authors: Le Gouill, Steven; Dreyling, Martin; Caballero, Maria Dolores; Andre, Marc; Doorduijn, Jeannette; Jurczak, Wojciech; Jerkeman, Mats; Ghia, Paolo; Zinzani, Pier-Luigi; Da Silva, Maria Gomez; Dimopoulos, Meletios; Trneny, Marek; Delarue, Richard; Walewski, Jan; Gisselbrecht, Christian; López-Guille... Journal: HemaSphere Issue: Volume 1:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial. Issue 3 (March 2016) Authors: Trněný, Marek; Lamy, Thierry; Walewski, Jan; Belada, David; Mayer, Jiri; Radford, John; Jurczak, Wojciech; Morschhauser, Franck; Alexeeva, Julia; Rule, Simon; Afanasyev, Boris; Kaplanov, Kamil; Thyss, Antoine; Kuzmin, Alexej; Voloshin, Sergey; Kuliczkowski, Kazimierz; Giza, Agnieszka; Milpied, No... Journal: Lancet oncology Issue: Volume 17:Issue 3(2016:Mar.) Page Start: 319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. Management perspective for mantle cell lymphoma. (February 2014) Authors: Shah, Nimish; Rule, Simon Journal: International journal of hematologic oncology Issue: Volume 3:Number 1(2014) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. New and emerging Bruton tyrosine kinase inhibitors for treating mantle cell lymphoma – where do they fit in?. Issue 9 (2nd September 2018) Authors: Rule, Simon; Chen, Robert W. Journal: Expert review of hematology Issue: Volume 11:Issue 9(2018) Page Start: 749 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. Novel agents in mantle cell lymphoma. Issue 6 (3rd June 2017) Authors: Tucker, David; Rule, Simon Journal: Expert review of anticancer therapy Issue: Volume 17:Issue 6(2017) Page Start: 491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗